# Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication

> **NCT02486289** · PHASE2 · COMPLETED · sponsor: **EmeraMed** · enrollment: 36 (actual)

## Conditions studied

- Mercury Poisoning

## Interventions

- **DRUG:** Emeramide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02486289
- **Lead sponsor:** EmeraMed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486289, "Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02486289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*